Green Thumb Industries (GTBIF) Stock Price, News & Analysis

Company Overview

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

Key Stats

• Today's Range: $5.42 to $5.97
• 50-Day Range: $5.52 to $7.43
• 52-Week Range: $5.37 to $16.33
• Volume: 455,159 shs
• Average Volume: 488,792 shs
• Market Capitalization: $1.25 billion
• P/E Ratio: 24.50
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Strong Buy

Green Thumb Industries Stock Analysis - MarketRank™

Green Thumb Industries scored higher than 68% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Strong Buy

Consensus Rating

Green Thumb Industries has received a consensus rating of Strong Buy. The company's average rating score is 3.60, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Green Thumb Industries has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 12.50%

Earnings Growth

Earnings for Green Thumb Industries are expected to grow by 12.50% in the coming year, from $0.32 to $0.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Green Thumb Industries is 24.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.74.

Price to Earnings Ratio vs. Sector

The P/E ratio of Green Thumb Industries is 24.50, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.13.

Price to Book Value per Share Ratio

Green Thumb Industries has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.18% of the float of Green Thumb Industries has been sold short.

Short Interest Ratio / Days to Cover

Green Thumb Industries has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Green Thumb Industries has recently increased by 2,502.36%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Green Thumb Industries does not currently pay a dividend.

Dividend Growth

Green Thumb Industries does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.18% of the float of Green Thumb Industries has been sold short.

Short Interest Ratio / Days to Cover

Green Thumb Industries has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Green Thumb Industries has recently increased by 2,502.36%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.32

News Sentiment

Green Thumb Industries has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Green Thumb Industries this week, compared to 2 articles on an average week.

Search Interest

34 people have searched for GTBIF on MarketBeat in the last 30 days. This is an increase of 36% compared to the previous 30 days.

MarketBeat Follows

11 people have added Green Thumb Industries to their MarketBeat watchlist in the last 30 days. This is an increase of 120% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Green Thumb Industries insiders have not sold or bought any company stock.

Percentage Held by Insiders

10.40% of the stock of Green Thumb Industries is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 0.09% of the stock of Green Thumb Industries is held by institutions.

GTBIF Stock Analysis - Frequently Asked Questions

How have GTBIF shares performed this year?

Green Thumb Industries' stock was trading at $8.17 at the start of the year. Since then, GTBIF stock has decreased by 28.0% and is now trading at $5.88.
View the best growth stocks for 2025 here.

How were Green Thumb Industries' earnings last quarter?

Green Thumb Industries Inc. (OTCMKTS:GTBIF) released its earnings results on Wednesday, February, 26th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.06 by $0.02. The firm had revenue of $294.32 million for the quarter, compared to analyst estimates of $289.66 million. Green Thumb Industries had a net margin of 5.38% and a trailing twelve-month return on equity of 3.39%.

How do I buy shares of Green Thumb Industries?

Shares of GTBIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 2/26/2025
• Today: 3/27/2025
• Next Earnings (Estimated): 5/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Agricultural production - crops
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:GTBIF
• CIK: 1795139
• Web: www.gtigrows.com
• Phone: 312-471-6720
• Fax: N/A
• Employees: 3,800
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $16.50
• High Stock Price Target: $17.00
• Low Stock Price Target: $16.00
• Potential Upside/Downside: +198.9%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.60
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.30
• Trailing P/E Ratio: 23.00
• Forward P/E Ratio: 17.25
• P/E Growth: N/A
• Net Income: $36.27 million
• Net Margins: 5.38%
• Pretax Margin: 16.32%
• Return on Equity: 3.39%
• Return on Assets: 2.32%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.40
• Quick Ratio: 1.72

Sales & Book Value

• Annual Sales: $1.05 billion
• Price / Sales: 1.11
• Cash Flow: $0.32 per share
• Price / Cash Flow: 17.27
• Book Value: $8.10 per share
• Price / Book: 0.68

Miscellaneous

• Outstanding Shares: 212,288,000
• Free Float: 187,513,000
• Market Cap: $1.17 billion
• Optionable: Not Optionable
• Beta: 1.30